Envoy Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Envoy Medical, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Revenue & Gross Profit
Revenue0.230.320.240.31
Cost of Revenue0.740.790.500.77
Gross Profit-0.52-0.47-0.26-0.46
Operating Expenses
Research & Development10.188.964.983.94
Selling, General & Administrative8.568.933.472.47
Operating Expenses18.7417.898.456.41
Operating Income-19.26-18.36-8.71-6.87
Other Income/Expense
Interest Income0.000.000.000.00
Interest Expense0.820.000.000.00
Other Income/Expense-0.72-11.56-7.22-1.80
Income
Income Before Tax-20.80-29.92-15.92-8.68
Income Tax Expense0.000.000.000.00
Net Income-20.80-29.92-15.92-8.68
Net Income - Continuous Operations-20.80-29.92-15.92-8.68
Net Income - Discontinued Operations0.000.000.000.00
EBITDA-19.81-29.79-8.63-6.80
EBIT-19.98-29.92-8.71-6.87
Depreciation & Amortization0.170.130.080.07
Earnings Per Share
Basic EPS-1.00-3.00-2.00-1.00
Diluted EPS-1.00-3.00-2.00-1.00
Basic Shares Outstanding18.7912.3010.1510.15
Diluted Shares Outstanding18.7912.3010.1510.15